Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0002126287-26-000001
Filing Date
2026-04-13
Accepted
2026-04-13 15:33:33
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 6974
  Complete submission text file 0002126287-26-000001.txt   8893
Mailing Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874
Business Address 20400 CENTURY BLVD SUITE 210 GERMANTOWN MD 20874 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Subject) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-93002 | Film No.: 26857663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1901 ULMERTON ROAD SUITE 400 CLEARWATER FL 33762
Business Address 1901 ULMERTON ROAD SUITE 400 CLEARWATER FL 33762 7275026022
International Generosity Foundation Trust (Filed by) CIK: 0002126287 (see all company filings)

EIN.: 843754469 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SCHEDULE 13D